Relmada Therapeutics Stock Forecast - Accumulation Distribution
| RLMD Stock | USD 3.90 0.06 1.52% |
Relmada Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Relmada Therapeutics stock prices and determine the direction of Relmada Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Relmada Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The value of RSI of Relmada Therapeutics' share price is at 51 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Relmada Therapeutics, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
Using Relmada Therapeutics hype-based prediction, you can estimate the value of Relmada Therapeutics from the perspective of Relmada Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Relmada Therapeutics after-hype prediction price | USD 3.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.Relmada Therapeutics Additional Predictive Modules
Most predictive techniques to examine Relmada price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Relmada using various technical indicators. When you analyze Relmada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 126486.0 | 0.14 |
| Check Relmada Therapeutics Volatility | Backtest Relmada Therapeutics | Information Ratio |
Relmada Therapeutics Trading Date Momentum
| On January 25 2026 Relmada Therapeutics was traded for 3.90 at the closing time. The top price for the day was 4.53 and the lowest listed price was 3.90 . There was no trading activity during the period 0.0. Lack of trading volume on January 25, 2026 did not cause price change. The trading delta at closing time against the current closing price is 10.51% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Relmada Therapeutics to competition |
Other Forecasting Options for Relmada Therapeutics
For every potential investor in Relmada, whether a beginner or expert, Relmada Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Relmada Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Relmada. Basic forecasting techniques help filter out the noise by identifying Relmada Therapeutics' price trends.Relmada Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Relmada Therapeutics stock to make a market-neutral strategy. Peer analysis of Relmada Therapeutics could also be used in its relative valuation, which is a method of valuing Relmada Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Relmada Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Relmada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relmada Therapeutics shares will generate the highest return on investment. By undertsting and applying Relmada Therapeutics stock market strength indicators, traders can identify Relmada Therapeutics entry and exit signals to maximize returns.
Relmada Therapeutics Risk Indicators
The analysis of Relmada Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Relmada Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting relmada stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.41 | |||
| Semi Deviation | 3.86 | |||
| Standard Deviation | 6.16 | |||
| Variance | 37.94 | |||
| Downside Variance | 19.8 | |||
| Semi Variance | 14.94 | |||
| Expected Short fall | (5.85) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Relmada Therapeutics
The number of cover stories for Relmada Therapeutics depends on current market conditions and Relmada Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Relmada Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Relmada Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Relmada Therapeutics Short Properties
Relmada Therapeutics' future price predictability will typically decrease when Relmada Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Relmada Therapeutics often depends not only on the future outlook of the potential Relmada Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Relmada Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 44.9 M |
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Relmada Therapeutics. If investors know Relmada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Relmada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Relmada Therapeutics is measured differently than its book value, which is the value of Relmada that is recorded on the company's balance sheet. Investors also form their own opinion of Relmada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Relmada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Relmada Therapeutics' market value can be influenced by many factors that don't directly affect Relmada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Relmada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relmada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.